Search Ontology:
ChEBI
riociguat
- Term ID
- CHEBI:76018
- Synonyms
-
- Adempas
- BAY 63-2521
- Methyl N-(4,6-diamino-2-{1-((2-fluorophenyl)methyl)-1H-pyrazolo(3,4-b)pyridin-3-yl}pyrimidin-5-yl)-N-methylcarbamate
- methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate
- riociguat
- riociguatum
- Definition
- A carbamate ester that is the methyl ester of {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamic acid. It is used for treatment of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension
- References
-
- cas:625115-55-1
- drugcentral:4807
- kegg.drug:D09572
- patent:US2009286781
- patent:WO2007009607
- patent:WO2011147810
- pmc:PMC3363218
- pubmed:19129292
- pubmed:20424448
- pubmed:20801938
- pubmed:20956169
- pubmed:21391889
- pubmed:21789188
- pubmed:22719060
- pubmed:22900035
- pubmed:22912874
- pubmed:22936711
- pubmed:23204120
- pubmed:23397304
- pubmed:23775260
- pubmed:23883377
- pubmed:23883378
- pubmed:23883383
- pubmed:23939482
- pubmed:23963798
- pubmed:23978639
- pubmed:23997048
- pubmed:23997053
- pubmed:24015306
- pubmed:24092345
- reaxys:12581953
- wikipedia.en:Riociguat
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from riociguat
Phenotype where environments contain riociguat
Phenotype modified by environments containing riociguat
Phenotype affecting riociguat
Human Disease Model